Simplex Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $164K | Buy |
+46,800
| New | +$192K | ﹤0.01% | 4535 |
|
|
2025
Q3 | – | Sell |
-5,800
| Closed | -$4K | – | 9505 |
|
|
2025
Q2 | $4K | Buy |
+5,800
| New | +$4.55K | ﹤0.01% | 7852 |
|
|
2025
Q1 | – | Sell |
-900
| Closed | -$3K | – | 9035 |
|
|
2024
Q4 | $3K | Sell |
900
-38,100
| -98% | -$155K | ﹤0.01% | 7883 |
|
|
2024
Q3 | $160K | Sell |
39,000
-8,300
| -18% | -$44.6K | ﹤0.01% | 4743 |
|
|
2024
Q2 | $308K | Sell |
47,300
-584,200
| -93% | -$4.13M | ﹤0.01% | 4191 |
|
|
2024
Q1 | $5.5M | Buy |
631,500
+446,100
| +241% | +$5.41M | ﹤0.01% | 1540 |
|
|
2023
Q4 | $2.12M | Buy |
185,400
+184,200
| +15,350% | +$1.82M | ﹤0.01% | 2307 |
|
|
2023
Q3 | $11K | Buy |
+1,200
| New | +$11.8K | ﹤0.01% | 7108 |
|
|
2023
Q2 | – | Sell |
-1,700
| Closed | -$17K | – | 9435 |
|
|
2023
Q1 | $17K | Sell |
1,700
-28,100
| -94% | -$315K | ﹤0.01% | 7065 |
|
|
2022
Q4 | $369K | Buy |
29,800
+2,600
| +10% | +$29.5K | ﹤0.01% | 3508 |
|
|
2022
Q3 | $281K | Buy |
27,200
+1,600
| +6% | +$18.1K | ﹤0.01% | 4163 |
|
|
2022
Q2 | $295K | Buy |
25,600
+13,700
| +115% | +$161K | ﹤0.01% | 4120 |
|
|
2022
Q1 | $149K | Sell |
11,900
-122,400
| -91% | -$1.4M | ﹤0.01% | 5590 |
|
|
2021
Q4 | $1.56M | Buy |
134,300
+95,200
| +243% | +$1.17M | ﹤0.01% | 2310 |
|
|
2021
Q3 | $505K | Hold |
39,100
| – | – | ﹤0.01% | 4100 |
|
|
2021
Q2 | $503K | Buy |
39,100
+38,522
| +6,665% | +$441K | ﹤0.01% | 4154 |
|
|
2021
Q1 | $646K | Sell |
578
-616
| -52% | -$6.51K | ﹤0.01% | 2987 |
|
|
2020
Q4 | $1.36M | Buy |
1,194
+1,174
| +5,870% | +$12.8K | ﹤0.01% | 2173 |
|
|
2020
Q3 | $17K | Sell |
20
-199
| -91% | -$1.98K | ﹤0.01% | 6455 |
|
|
2020
Q2 | $226K | Buy |
219
+63
| +40% | +$645 | ﹤0.01% | 3853 |
|
|
2020
Q1 | $157K | Buy |
156
+138
| +767% | +$1.62K | ﹤0.01% | 3867 |
|
|
2019
Q4 | $23K | Sell |
18
-163
| -90% | -$1.8K | ﹤0.01% | 5839 |
|
|
2019
Q3 | $155K | Buy |
181
+9
| +5% | +$87 | ﹤0.01% | 3836 |
|
|
2019
Q2 | $187K | Sell |
172
-51
| -23% | -$571 | ﹤0.01% | 3527 |
|
|
2019
Q1 | $253K | Buy |
223
+16
| +8% | +$179 | ﹤0.01% | 3360 |
|
|
2018
Q4 | $179K | Sell |
207
-213
| -51% | -$2.44K | ﹤0.01% | 3268 |
|
|
2018
Q3 | $649K | Sell |
420
-829
| -66% | -$13.1K | ﹤0.01% | 2342 |
|
|
2018
Q2 | $2M | Buy |
1,249
+890
| +248% | +$13.2K | 0.01% | 1152 |
|
|
2018
Q1 | $31K | Buy |
359
+253
| +239% | +$3.15K | ﹤0.01% | 2906 |
|
|
2017
Q4 | $2K | Sell |
106
-170
| -62% | -$2.22K | ﹤0.01% | 5195 |
|
|
2017
Q3 | $32K | Buy |
276
+47
| +21% | +$647 | ﹤0.01% | 2721 |
|
|
2017
Q2 | $24K | Buy |
229
+92
| +67% | +$1.34K | ﹤0.01% | 3126 |
|
|
2017
Q1 | $6K | Buy |
137
+87
| +174% | +$1.19K | ﹤0.01% | 4430 |
|
|
2016
Q4 | $2K | Sell |
50
-510
| -91% | -$6.44K | ﹤0.01% | 5052 |
|
|
2016
Q3 | $64K | Buy |
560
+516
| +1,173% | +$6.03K | ﹤0.01% | 1902 |
|
|
2016
Q2 | $4K | Sell |
44
-66
| -60% | -$645 | ﹤0.01% | 4434 |
|
|
2016
Q1 | $5K | Buy |
+110
| New | +$907 | ﹤0.01% | 4089 |
|
|
2015
Q4 | – | Sell |
-110
| Closed | -$1K | – | 5726 |
|
|
2015
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 5034 |
|
|
2015
Q2 | $2K | Buy |
110
+79
| +255% | +$918 | ﹤0.01% | 4294 |
|
|
2015
Q1 | $7K | Sell |
31
-2
| -6% | -$26 | ﹤0.01% | 3224 |
|
|
2014
Q4 | $8K | Buy |
+33
| New | +$378 | ﹤0.01% | 2736 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Simplex Trading's IRWD Position: Q1 2026 in Review
Simplex Trading opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 17,724 shares worth $62.2K. The stake represents ﹤0.01% of the portfolio and ranks #5625 among its holdings. This is a return to the name: Simplex Trading previously reported a position in IRWD as recently as Q3 2025.
Simplex Trading first reported a position in IRWD in Q1 2015 and has held it in 30 quarters since. The position peaked at $714K in Q1 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Simplex Trading held 17,724 shares of Ironwood Pharmaceuticals worth $62.2K as of Q1 2026.
- Ironwood Pharmaceuticals was a new Simplex Trading position in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5625 holding.
- Simplex Trading first reported a position in Ironwood Pharmaceuticals in Q1 2015 and has held it in 30 quarters since.
- Simplex Trading's Ironwood Pharmaceuticals position peaked at $714K in Q1 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.